Epidemiological significance of chronic pharyngitis, nasopharyngitis, sinusitis, and rhinitis in Moscow and the Russian Federation in 1996 to 2009
https://doi.org/10.17650/1818-8338-2012-3-4-38-43
Abstract
Objective: to study trends in the incidence and prevalence of chronic pharyngitis, nasopharyngitis, sinusitis, and rhinitis (CPNSR) in different
age groups in Moscow and the Russian Federation (RF) in the period 1996 to 2009.
Materials and methods. The epidemic significance of CPNSR in Moscow and the RF was estimated, by analyzing the records available in the annual official statistical sources (Form No. 12).
Results. The incidence of CPNSR in Moscow in the study period remains lower than those in the RF. Its prevalence among the population in the city and in the country as a whole shows a significant increasing trend. Among the adolescents in both Moscow and the RF, the incidence of CPNSR is higher than that in children and constitutes 24.4 and 31.6 versus 3.3 and 21.8 per 10,000 population, respectively. The children
and adolescents in the RF are the highest risk groups in the incidence of CPNSR. In 2009, its prevalence rates in Moscow and the RF were 99.5 and 121.3 per 10,000, respectively; which were well above those in 2007 (81.2 and 117.5 per 10,000, respectively).
Conclusion. The high incidence and prevalence rates for CPNSR remain high in all population strata in Moscow and the RF, which may be associated with decreased diagnostic alertness and inadequate treatment for upper airway diseases.
Keywords
About the Authors
A. V. AksyonovaRussian Federation
A.I. Nesterov Department of Faculty of Therapeutics
N. I. Briko
Russian Federation
Department of Epidemiology and Evidence-Based Medicine
D. A. Kleimenov
Russian Federation
Department of Epidemiology and Evidence-Based Medicine
References
1. Александровский А.А., Колпаков Е.В., Романов М.Д. и др. Ревматизм сегодня – региональная характеристика. Рос кардиол журн 2006;(4):7–12.
2. Шостак Н.А. Острая ревматическая лихорадка: взгляд на проблему в XXI веке. Клиницист 2010;(1):5–8.
3. Белов Б.С., Кузьмина Н.Н. Острая ревматическая лихорадка. Научно-практическая ревматология
4. ;2(прил):3–8.
5. Carapetis J.R., Mayosi B.M., Kaplan E.L. Controlling rheumatic heart disease in developing countries. Cardiovasc J South Afr 2006;17(4):164–5.
6. Schuchat A. Group B streptococcus. Lancet 1999;353(9146):51–6.
7. Schwartz B., Facklam R.R., Brieman R.F. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990;336(8724):1167–71.
8. Покровский В.И., Пак С.Г., Брико Н.И., Данилкин Б.К. Инфекционные болезни и эпидемиология. М.: ГЭОТАР-Медиа, 2007.
9. Школьникова М.А. Сердечно-сосудистые заболевания детского возраста на рубеже XXI века. Consilium medicum 1999;1(6):7–11.
10. Mattei P., Bequinot I., Malet T. et al. Meningitis, septicemia and endophthalmiyis caused by Streptococcus equi subspecies zooepidemicus (in French). Presse Med 1995;24(23):1089.
11. Ряпис Л.А., Брико Н.И., Ещина А.С., Дмитриева Н.Ф. Стрептококки. Общая характеристика и методы лабораторной диагностики. Под ред. Н.И. Брико. М.: Медицинское информационное
12. агентство, 2009.
13. Насонова В.А. Ревматическая лихорадка (ревматизм): настоящее и будущее. Врач 1999;5:4–6.
14. Хатеневер М.Р., Яхнина Н.А., Угрюмова Г.А. и др. Распространение стрептококков разных типов при стрептококковых заболеваниях. Журн микробиол, эпидемиол и иммунобиол 1968;45(3):111–7.
15. Leiner S. Surveillance for rheumatic fever. N Engl J Med 1996;334(4):273–4.
16. Брико Н.И., Жуков В.В. Концепция механизма развития эпидемического процесса респираторно-стрептококковой инфекции в организованном коллективе. Нижегор мед журн 1992;(1):23–7.
17. Красильников И.А., Ионтова И.М., Соболевская А.А. и др. Общая характеристика эпидемического процесса и циркулирующих штаммов стрептококка в период подъема заболеваний скарлатины в Ленинграде. Журн микробиол, эпидемиол и иммунобиол 1990;(1):33–6.
18. Беляков В.Д., Ходырев А.П., Тотолян А.А. Стрептококковая инфекция. Л.: Медицина, 1978.
19. Azpitarte J., Alonso A.M., Garcia Gallego F. et al. Guidelines of the Spanish Society of Cardiology on valve heart disease (in Spanish). Rev Esp Cardiol 2000;53(9):1209–78.
20. Bert F., Bariuo-Lancelin M., Lambert-Zechovsky N. Clinical significance of bacteremia involving the Streptococcus milleri group: 51 cases and review. Clin Infect Dis 1998;27(2):385–7.
21. Dajani A., Taubert K., Ferrieri P. et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the
22. American Heart Association. Pediatrics 1995;96(4 Pt 1):758–64.
23. Skitarelić N., Morović M., Belić V. et al. Post-streptococcal reactive arthritis: diagnostic problems (in Croatian). Lijec Vjesn 1996;118(3–4):53–6.
24. Luca-Harari B., Ekelund K., van der Linden M. et al. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections inDenmark during 2003and2004.J Clin Microbiol2008;46(1):79–86.
25. Silva F.G. Acute postinfectious glomerulonephritis and glomerulonephritis complicating
26. persistent bacterial infection. In: Pathology of the kidney. Ed. by R.H. Hepinstall. 5th ed. Phladelphia:
27. Lippincott-Raven Publishers, 1998. Pр. 389–453.
28. Насонова В.А., Фоломеева О.М., Эрдес Ш.Ф. Ревматические болезни в России в начале XXI века. Научно-практическая ревматология 2003;(1):6–10.
29. Тотолян А.А. Стрептококковая инфекция. В кн.: Руководство по эпидемиологии инфекционных болезней. Под ред. В.И. Покровского. М.: Медицина, 1993. Т. 2. С. 245–260.
Review
For citations:
Aksyonova A.V., Briko N.I., Kleimenov D.A. Epidemiological significance of chronic pharyngitis, nasopharyngitis, sinusitis, and rhinitis in Moscow and the Russian Federation in 1996 to 2009. The Clinician. 2012;6(3-4):38-43. (In Russ.) https://doi.org/10.17650/1818-8338-2012-3-4-38-43